Credit Suisse has wasted no time in making good on last week's investor day pledge to recruit more coverage managing directors as part of a push to grow its investment banking revenues by $750 million, with the hire of five former Barclays Americas healthcare bankers.

Between them, the five bankers have worked on deals worth more than $64 billion over the past three years, including Teva's announced acquisition of Allergan's generics business for $40.5 billion and Endo's $8.05 billion acquisition of Par Pharmaceutical.